Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
about
HIGD1A Regulates Oxygen Consumption, ROS Production, and AMPK Activity during Glucose Deprivation to Modulate Cell Survival and Tumor GrowthSTUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagyAbnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.Carbonic anhydrase IX in oligodendroglial brain tumors.High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia.Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system.In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumorsMembrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerDetection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.Hypoxia as a biomarker for radioresistant cancer stem cells.The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels.EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvateMicroenvironments and cellular characteristics in the micro tumor cords of malignant solid tumorsWortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population.Involvement of decreased hypoxia-inducible factor 1 activity and resultant G1-S cell cycle transition in radioresistance of perinecrotic tumor cells.Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiformeThe key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.Immunohistochemical detection of changes in tumor hypoxiaThe prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response.Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.Molecular Imaging of Hypoxia: Strategies for Probe Design and Application.Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathwaysBioimaging of fluorescence-labeled mitochondria in subcutaneously grafted murine melanoma cells by the "in vivo cryotechnique".Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20).Oxygen consumption in T-47D cells immobilized in alginate.Prognostic value of HIF-1α expression during fractionated irradiation.Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomasImaging and Targeting of the Hypoxia-inducible Factor 1-active Microenvironment.Transforming growth factor-β signaling enhancement by long-term exposure to hypoxia in a tumor microenvironment composed of Lewis lung carcinoma cells.Hypoxia inducible factor-1α is necessary for invasive phenotype in Vegf-deleted islet cell tumors.HIGD1A-mediated dormancy and tumor survival.Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.Radiolabeled probes targeting hypoxia-inducible factor-1-active tumor microenvironments.
P2860
Q28505980-F0E73F6C-CB5F-4D50-AB00-7177CDE9B628Q28568829-D1CD3D99-7272-4DDB-99E1-BBCD9BDB0D32Q30523799-081AA904-34DA-4994-B743-A23E33B71B63Q33313215-3343211F-AA57-4C39-8F10-6F5751B85DB7Q33547295-F7DD6A00-5F91-41A1-884B-58AE1B60E87FQ33588105-3EAEF762-422B-45BE-8087-4F439752E157Q33784382-AF68E647-DE35-41DF-B538-96445A7D9F8CQ33816406-519B3F19-5DDD-4E1E-AE70-D442B2D35093Q33856008-2688E5A5-B753-42E4-AF40-38E24DE36648Q33936624-A5CD9789-97BD-4CA2-AE94-6CF2DAEB40D8Q34017131-373FC55E-CBF5-4998-9792-9CF55D26504AQ34420732-3C0652E1-0D94-4EED-9558-435A7D198AE9Q35029578-4E66D6B3-C832-47FA-B621-A3FDC540983DQ35821578-607BE656-4F62-4E00-A4F6-238F072FA5D8Q35916654-59CB30E8-5F55-494B-B23F-F1F58FF09255Q36342034-98ACD198-B356-4C7D-BEF8-DF6F7623775BQ36432405-D0169D69-CE51-4CF1-B589-6F20717D0843Q36661392-F74A93EF-561E-421A-BFDE-EB9C1452C38DQ36780880-695433CC-68D5-4412-BF8A-7D42E3D18D99Q36952855-67D5E815-9E1B-4E0C-96C1-7CF12587FE2FQ37081132-99615973-BFDA-41E1-8F83-5BED2DC3B70FQ37188441-41385177-9B27-4E15-A285-7B7E005EA8F8Q37214341-367F28C5-9F67-410E-8B02-2389FC269B91Q37330712-0DF032C5-5EB3-4B01-9A55-FE87F33D7A86Q37433326-F54C10B6-CCF6-4C51-8C80-2EB30E3F6264Q37617542-18273754-E871-45F1-9093-17EDF270A8B4Q37986039-FF540485-EA8D-4B9D-8394-DA850DA43F46Q38154554-9D2D7EF1-6811-42C9-BC47-00942045B613Q38184665-AE2E6B1B-09B0-4844-88F7-08DB6C7E0CB4Q38522162-8648F014-0E56-4736-B33F-8314F03F9873Q38786691-C7EB47B5-8EEF-435F-B627-2D81536ECE09Q39123439-303CC55E-7683-4F28-ADE7-8308FF8D376FQ39262531-E63B8611-AA29-468B-B915-D13AE833CA7BQ39285064-EBAEA6CF-1997-4B49-9037-1D4B2CCC25CCQ39993165-5A1814AF-6940-406B-9B9F-8817533023CDQ42131856-F75E0666-D008-413A-850F-7D6BCE818EF9Q42224769-E1F473A4-AAA1-4D3A-9558-906EEA343A9EQ42227940-75FDB086-69A2-4E3C-A253-DD85F30C63D5Q42510147-C9703BEB-FFFD-4A6C-A17F-16C014A28412Q53051729-C8BD9F55-40AF-4E0F-96CC-D54E944D4A6B
P2860
Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Reduced expression of hypoxia- ...... rotic regions of solid tumors.
@en
type
label
Reduced expression of hypoxia- ...... rotic regions of solid tumors.
@en
prefLabel
Reduced expression of hypoxia- ...... rotic regions of solid tumors.
@en
P2093
P1433
P1476
Reduced expression of hypoxia- ...... crotic regions of solid tumors
@en
P2093
Christina Aquino-Parsons
Eric J Stanbridge
Peggy Olive
P304
P356
10.1158/0008-5472.CAN-04-4480
P407
P577
2005-08-01T00:00:00Z